Avalo Therapeutics, Inc. AVTX
AVTX
Avalo Therapeutics, Inc. PRLD
Prelude Therapeutics Incorporated IVA
Inventiva S.A. EPRX
Eupraxia Pharmaceuticals Inc. CRBU
Caribou Biosciences, Inc. CHRS
Coherus Oncology, Inc. OBIO
Orchestra BioMed Holdings, Inc. AARD
Aardvark Therapeutics, Inc. Common Stock TNYA
Tenaya Therapeutics, Inc. ENTA
Enanta Pharmaceuticals, Inc.
Avalo Therapeutics, Inc. PRLD
Prelude Therapeutics Incorporated IVA
Inventiva S.A. EPRX
Eupraxia Pharmaceuticals Inc. CRBU
Caribou Biosciences, Inc. CHRS
Coherus Oncology, Inc. OBIO
Orchestra BioMed Holdings, Inc. AARD
Aardvark Therapeutics, Inc. Common Stock TNYA
Tenaya Therapeutics, Inc. ENTA
Enanta Pharmaceuticals, Inc.
Performance
| Periode | AVTX | PRLD | IVA | EPRX | CRBU | CHRS | OBIO | AARD | TNYA | ENTA |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 304.41 % | 126.45 % | 30.36 % | 48.35 % | 26.56 % | 75.87 % | 43.81 % | 9.44 % | 15.30 % | 97.10 % |
| YTD | 128.35 % | 56.00 % | 104.67 % | 100.96 % | -3.57 % | -3.57 % | -20.07 % | -7.62 % | -53.03 % | 154.92 % |
| 1Y | 107.44 % | 115.16 % | 92.11 % | 97.18 % | -8.99 % | -14.01 % | -9.66 % | -7.62 % | -45.77 % | 143.59 % |
| 3Y | -98.56 % | -60.53 % | -2.67 % | 113.22 % | -76.11 % | -80.77 % | -56.87 % | -7.62 % | -67.30 % | -66.69 % |
| 5Y | -99.75 % | -97.44 % | -64.22 % | 113.22 % | -90.07 % | -92.26 % | -64.05 % | -7.62 % | -95.65 % | -67.67 % |
| 10Y | -99.79 % | -92.56 % | -67.36 % | 113.22 % | -90.07 % | -93.98 % | -62.28 % | -7.62 % | -95.65 % | -55.09 % |
| From the beginning | -99.90 % | -92.56 % | -67.36 % | 113.22 % | -90.07 % | -89.29 % | -62.28 % | -7.62 % | -95.65 % | -17.05 % |